 |
 |
||||||
 |
Our customers' Feedback |
Your cart
| |||||
Generic Levonorgestrel - Plan B
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth.
- Sildenafil citrate and pulmonary arterial hypertension
Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure.
- Fruit and vegetables do not reduce overall cancer risk, review concludes
Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people.
- Common painkillers could be linked to male reproductive disorder
The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study.
- Studies Show Conflicting Findings on Risk of VTE with NuvaRing - InjuryBoard.com
Studies Show Conflicting Findings on Risk of VTE with NuvaRingInjuryBoard.
- Contraceptive patches and vaginal rings 'double thrombosis risk' - Pulse
Contraceptive patches and vaginal rings 'double thrombosis risk'PulseExperts warned the 'extremely concerning' study results could undo years of work reducing teenage pregnancies, but the authors urged GPs to use oral levonorgestrel or norgestimate- based contraceptives to reduce the risk of VTEs.
- Safer than non-oral contraception? - HeartZine
Zee NewsSafer than non-oral contraception?HeartZineThe results show that if a woman shifts from a patch or vaginal ring to levonorgestrel intrauterine system, she will no longer be at an increased risk of venous thrombosis, while if she shifts to a 2nd generation pill (with levonorgestrel) she will .
- New Phase III Data Show Agile Therapeutics' Low-Dose Patch Is Comparable to ... - MarketWatch (press release)
New Phase III Data Show Agile Therapeutics' Low-Dose Patch Is Comparable to .
- ACOG: Intrauterine Device Insertion Linked to Weight Loss - Doctors Lounge
ACOG: Intrauterine Device Insertion Linked to Weight LossDoctors LoungeWomen who undergo postpartum or interval insertion of Levonorgestrel-releasing Intrauterine System or Copper T 380A intrauterine devices experience weight loss in the two years following insertion, according to a study presented at the annual clinical .
|
| Copyright © www.pillsed.us is an affiliate marketing website. All rights reserved. |